Business people

Published 10:30 pm, Friday, December 20, 2013

Bill Collier has been named managing partner at Lindsey & Co., and is based in the executive search firm's Darien office. Before joining Lindsey, Collier's 28-year career included various sales, marketing and general management roles. He was responsible for leading Premier Retail Networks (now IZ-ON Media) covering client accounts and agencies. As an executive team member, Collier was responsible for the national sales team, employee training development and all revenue. Prior to joining PRN, his work history included roles at The Perrier Group (now Nestle Waters), Nielsen Media Research, Pepsi-Cola, Catalina Marketing and News Corp. Collier earned a bachelor's degree in finance from Providence College and has served on the board of directors for MAC Angels Foundation and Friends of Claire Foundation. He lives in Stamford.

Kristofer Kwait, managing director at Commonfund, an institutional investment firm in Wilton, has added another title, head of hedge fund research, to his job description. Kwait, a 12-year veteran of the firm, has supervised the group's quantitative analytics team, quantitative due diligence and ongoing risk management processes, in addition to manager selection. Kwait has also co-published a collection of whitepapers on various aspects of hedge fund investing. These include "Hedge Funds as Diversifiers in Institutional Portfolios~2013"; "Understanding the Managed Futures Strategy and its Role in an Institutional Policy Portfolio~2012"; "A Look at Market Conditions Affecting Equity Hedge Fund Capture Ratios~2010."

Walter Capone has been promoted from chief operating officer to president of the Multiple Myeloma Research Foundation. He will report to Kathy Giusti, MMRF founder and CEO. Capone joined the MMRF in 2010 as chief operating office, where he focused his efforts on bringing together researchers and clinicians with the pharma, biotechnology and diagnostic industries. He led the development of the MMRF CoMMpass Study, a longitudinal study involving more than 50 academic and community centers in following 1,000 myeloma patients from the time of their diagnosis through their journey with the disease. Capone has 20 years of pharmaceutical and biotechnology leadership experience in the areas of commercial development, operations, finance, marketing and sales, in the U.S and abroad. Before joining the MMRF, he was vice president of commercial development and operations at Progenics Pharmaceuticals, working with their global partner Wyeth/Pfizer. Capone received his bachelor's degree in international relations from Brown University, and he has a master's degree in business administration, finance and international business, from Columbia University Business School.